Malcolm J. Moore, M.D., F.R.C.P.C.
Dr. Moore did his undergraduate work in the honours mathematics program
at the University of Waterloo focusing on statistics and computer science. He received his MD from the University of Western Ontario in London and did his postgraduate training in Internal Medicine and Medical Oncology at the University of Toronto. Dr. Moore is a Professor of Medicine and Pharmacology in the Division of Medical Oncology and Hematology at Princess Margaret Hospital, University of Toronto and a Senior Scientist in the Division of Experimental Therapeutics at the Ontario Cancer Institute. Dr Moore is Director of the Robert and Maggie Bras and Family New Drug Development Program at PMH and is a principal investigator in the PMH Phase II Consortium; a PMH based alliance cancer centres that won a contract with NCI ensuring access to new NCI anti-cancer drugs He is the chair of the GI committee for National Cancer Institute of Canada [NCIC] and an executive member of the North American GI Intergroup. He is also the holder of the Ho Chair for New Drug Development in Prostate Cancer and is an executive member of the NCIC Investigational New Drug Committee.